| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/28/2005 | EP0859840B1 Biologically active eph family ligands |
| 12/28/2005 | EP0805683B1 5-fluoro-2',3'-unsaturated-pyrimidine nucleosides |
| 12/28/2005 | EP0797676B1 Recombinant adenoviral vector and methods of use |
| 12/28/2005 | EP0778836B1 Substituted 9-alkyladenines |
| 12/28/2005 | EP0705103B1 Use of notoginsenoside r1 for the treatment of endotoxin shock or heart diseases |
| 12/28/2005 | CN1714571A Circuit for processing video signal containing information such as closed caption |
| 12/28/2005 | CN1714151A Novel glutamate receptor modulatory proteins and nucleic acid molecules and uses therefor |
| 12/28/2005 | CN1714136A Composition containing high oxygen stabilized double bonded organic compound |
| 12/28/2005 | CN1714135A External composition containing highly unsaturated fatty acid or its salt or ester |
| 12/28/2005 | CN1714098A Crystalline and amorphous forms of beta-l-2'-deoxythymidine |
| 12/28/2005 | CN1714096A Mmp inhibitors |
| 12/28/2005 | CN1714090A Quinolinyl-pyrrolopyrazoles |
| 12/28/2005 | CN1714089A Novel use of substituted aminomethyl chromans |
| 12/28/2005 | CN1714084A Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 12/28/2005 | CN1714082A Process for preparation of imidazolyl compounds |
| 12/28/2005 | CN1714079A Mandelic acid derivatives |
| 12/28/2005 | CN1714078A Indoles useful in the treatment of androgen-receptor related diseases |
| 12/28/2005 | CN1714077A 2-,3-4- or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy. |
| 12/28/2005 | CN1713926A Peritoneal dialysis method |
| 12/28/2005 | CN1713923A Pharmaceutical compositions having a modified vehicle |
| 12/28/2005 | CN1713922A Combinations of (a) an ATP-competitive inhibitor of c-acl kinase activity with (b) two or more other antineoplastic agents |
| 12/28/2005 | CN1713918A Muscle building preparation |
| 12/28/2005 | CN1713917A Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of myelodysplastic syndromes |
| 12/28/2005 | CN1713916A NADH/NADPH-containing compound |
| 12/28/2005 | CN1713915A Methods for preventing and treating bone loss with steroid compounds |
| 12/28/2005 | CN1713914A Novel medicaments for the treatment of chronic obstructive pulmonary diseases |
| 12/28/2005 | CN1713913A Inclusion complex of anti-tubercular rifampicin with Beta-cyclodextrin or 2-Hdroxypropyl Beta-Cyclodextrin and a process for producing the same |
| 12/28/2005 | CN1713912A Use of levocetirizine for the treatment of persistent allergic rhinitis |
| 12/28/2005 | CN1713911A Medicament component of berberine for the use of prevention and treatment of psycological dependence on and analgesic tolerance to morphine |
| 12/28/2005 | CN1713910A Azaindole derivatives as inhibitors of p38 kinase |
| 12/28/2005 | CN1713909A Aminoindazole derivatives and use thereof as kinase inhibitors |
| 12/28/2005 | CN1713908A Aminoalkoxyindoles as 5-HT6-receptor ligands for the treatment of CNA-disorders |
| 12/28/2005 | CN1713907A N-substituted pyrrolidin derivatives as dipeptidyl peptidase IV inhibitors |
| 12/28/2005 | CN1713906A Treatment of gastrointestinal disorders with duloxetine |
| 12/28/2005 | CN1713905A Selective cytokine inhibitory drugs for treating myelodysplastic syndrome |
| 12/28/2005 | CN1713904A Anthranilic acid amides and the derivatives thereof as cosmetic and pharmaceutical agents |
| 12/28/2005 | CN1713903A New synergistic combination comprising roflumilast and formoterol |
| 12/28/2005 | CN1713902A Synergistic combination comprising roflumilas and (R,R) -formoterol |
| 12/28/2005 | CN1713901A Hydroxypropylmethylcellulose capsule preparation having teprenone encapsulated therein |
| 12/28/2005 | CN1713900A Use of norepinephrine reuptake inhibitors for the treatment of cognitive failure |
| 12/28/2005 | CN1713899A Transdermal therapeutic system with fentanyl or related substances |
| 12/28/2005 | CN1713895A Increased-dosage nelfinavir tablet and method of making same |
| 12/28/2005 | CN1713894A Method for preparing a compound of interaction of active substances with a porous support using supercritical fluid |
| 12/28/2005 | CN1713888A Cream for treatment of skin injured by the sun |
| 12/28/2005 | CN1713827A Functional foods/drinks containing antiallergic component |
| 12/28/2005 | CN1713826A Milk product comprising unesterified sterol |
| 12/28/2005 | CN1712016A Injection liquid of doxifluoridine |
| 12/28/2005 | CN1712015A Sustained tablets of staffdine and their preparing method |
| 12/28/2005 | CN1712014A Use of liquiritigenin |
| 12/28/2005 | CN1712013A Asiaticoside use of medicinal preparation for treating and preventing chronic renal failure |
| 12/28/2005 | CN1712012A Preparation containing compound gentamicin procaine |
| 12/28/2005 | CN1712011A Dispersed tablet sof tannic matrine and their preparing method |
| 12/28/2005 | CN1712010A 5-amino-salicylic acid intercalation medicinal slow-release agent and production thereof |
| 12/28/2005 | CN1712009A Externally-applied medicinal liquid for treating acne, rosacea and folliculitis |
| 12/28/2005 | CN1712008A Ceftizoxime sodium compound preparation |
| 12/28/2005 | CN1712007A Medicinal composition for treating chronic nasosinusitis and production thereof |
| 12/28/2005 | CN1712006A Eye drop of giatishacin |
| 12/28/2005 | CN1712005A Oral capsules of topticon |
| 12/28/2005 | CN1712004A Viganitis supplying preparation containing composite methyl nitrozole |
| 12/28/2005 | CN1712003A Medicinal composition for viganitis |
| 12/28/2005 | CN1712002A Osmotic pumping sustained preparation of ropinirole hydrochloride and its preparing method |
| 12/28/2005 | CN1712001A Catechin microcapsules production |
| 12/28/2005 | CN1712000A Enantiomophous kauri pine alkane style diterpine compound microcaspules and their preparation |
| 12/28/2005 | CN1711999A Fat milk infusion with biological activity and production thereof |
| 12/28/2005 | CN1711998A Multi-dimensional acetylcysteine solution with stabilized pH near to neutrality and production thereof |
| 12/28/2005 | CN1711997A 5-keto-amine pentanoic acid salt externally-applied preparation and production thereof |
| 12/28/2005 | CN1711996A Injectable pharmaceutical compositions comprising sodium diclofenac and beta-cyclodextrin |
| 12/28/2005 | CN1711995A Use of Chinese small iris seed extract A and its derivative and analogs in preparation of anti-cancer medicine |
| 12/28/2005 | CN1711994A Use of Chinese small iris seed extract A and its derivative and similar materials in preparation of chemical therapeutical sensitizing agent |
| 12/28/2005 | CN1711993A Coferment Q10 microcapsule and production thereof |
| 12/28/2005 | CN1233884C Process for preparing low defect density silicon using high growth rates |
| 12/28/2005 | CN1233663C Preparation of carboxymethyl chitin bismuth and its application in treating gastritis and gastrelcoma |
| 12/28/2005 | CN1233649C Compound Bajisu A and its preparation and use |
| 12/28/2005 | CN1233645C Novel oripavine derivative and its medical use |
| 12/28/2005 | CN1233643C Ramification of a compound of medication as well as preparation method and application |
| 12/28/2005 | CN1233629C Sulfolipid compound with neural nourishing function and synthetic method and application thereof |
| 12/28/2005 | CN1233621C Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same |
| 12/28/2005 | CN1233613C Resveratrol oxo acid derivatives, their preparation and pharmaceutical compositions |
| 12/28/2005 | CN1233612C Hydroxyanthraquinone derivatives and their application in preparation of anticancer medicines |
| 12/28/2005 | CN1233420C Method for preparation of polymeric micelle via separation of block copolymer |
| 12/28/2005 | CN1233418C Heat-resisting lyophilized protectant for chicken newcastle disease, chicken infectious bronchitis (H120, H52) dual lyophilized vaccine and preparing process thereof |
| 12/28/2005 | CN1233358C Method for extracting substance resisting respiratory syncytial virus from patrinia |
| 12/28/2005 | CN1233328C Cell growth regulating factor K and its preparation process |
| 12/28/2005 | CN1233327C Highly effective sustained release breviscapine compositions and its granule capsule |
| 12/28/2005 | CN1233326C Use of glede tea alcohol extract in preparation of antiphlogistic immune pharmaceutical |
| 12/28/2005 | CN1233325C Drug for treatment of osteonecrosis and for management of patients at risk of steonecrosis |
| 12/28/2005 | CN1233324C Use of composition of intraocular pressure reducing agent |
| 12/28/2005 | CN1233323C Orally disintegrating tablet of meloxicam and its preparation |
| 12/28/2005 | CN1233322C Method for producing xinnaoning injection containing chuanxiong rhizome and red sage root extract |
| 12/28/2005 | CN1233321C Rheumatism soft capsule and its preparation method |
| 12/28/2005 | CN1233320C Slow-releasing microball with nimoldipine and its preparing method |
| 12/28/2005 | CN1233319C Indapamide slow release capsule and preparation method |
| 12/28/2005 | CN1233318C Hepadestal soft capsule and its preparing method |
| 12/28/2005 | CN1233317C Milk thistle silybum marianum self-emulsified micro-emulsion composition and its preparation process |
| 12/28/2005 | CN1233316C Use of asafetida extract in production of medicine |
| 12/28/2005 | CN1233315C Sibutramine hydrochloride guttate pill |
| 12/28/2005 | CN1233314C Metoprolol dripping pills and the preparation process thereof |
| 12/28/2005 | CN1233312C Liposome anti-fungus medication sprayer formulation |
| 12/28/2005 | CN1233311C Compound ointment for treating fungous dermatosis |
| 12/28/2005 | CN1233257C A composition containing carvacrol and thymol for use as abactericide |